BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Emergent Technologies, Inc. Announces Executive Appointments to Support Growth Initiatives


10/2/2012 8:46:07 AM

AUSTIN, TX -- October 3, 2012 – Emergent Technologies, Inc. (Emergent), a leading innovation solutions company, announced today management changes to realign senior executives in support of ongoing growth initiatives and increasing partnership opportunities. Kris Looney has been named President and Brian Windsor appointed Executive Vice President and Director of Life Sciences.

“As a result of Emergent’s recent and continuing success and growth, it is an appropriate time to appoint a new President,” said Thomas A. Harlan, Emergent CEO and former company president. “Given Kris’ increasing responsibilities and significant contributions over the years, he is the natural person to fill this leadership position. His experience and business acumen have proven valuable and this appointment will allow him to more directly lead strategy and operational effectiveness throughout our multi-channel innovation solutions business.”

Newly appointed Emergent President Kris Looney has been with the company for seven years. He initially joined Emergent as Business Development Director where he had an immediate impact establishing key profitable partnerships. Then, as Managing Director and later as President of three Emergent portfolio companies, he applied his experience in technology development, commercialization and partnering and became a driver in modeling the innovation engine the company now employs to accelerate technology into the marketplace. Mr. Looney is a business generalist with a diverse background in management, marketing, sales and relationship-building. Prior to joining Emergent, Mr. Looney served as the COO and Interim CEO of the American Red Cross of Central Texas and as the CFO of Transformation Enzyme Corporation. Mr. Looney holds a B.A. degree in marketing and an M.B.A. from the University of Texas at Austin.

In another senior management change, Brian Windsor, Ph.D., has been appointed Executive Vice President and Director of Life Sciences with responsibility for overseeing Emergent’s current portfolio of life science opportunities as well as establishing the direction for future life science endeavors. Dr. Windsor has been involved in research, development and management of startup life science companies for the past 14 years, eight of them with Emergent. Dr. Windsor has served in a number of roles in ten of Emergent’s portfolio companies including Chief Scientist, Chief Technical Officer, President and Managing Director. He has led many of the company’s life science-related services such as technical strategy for third party startup companies and technology identification services for clients like Merck Pharmaceuticals. Dr. Windsor is the co-inventor on numerous patents. He holds a Ph.D. in molecular biology from the University of Texas at Austin.

Emergent CEO Thomas A. Harlan commented, “Brian’s substantial expertise and life science leadership have helped us build a robust portfolio of technology assets and to respond to clients with innovative solutions that provide outcomes with value. In his new position, Brian will continue to accelerate Emergent’s efforts in identifying and developing those differentiating life science opportunities that address the industry’s biggest challenges and improve quality of life.”

About Emergent Technologies, Inc.

Headquartered in Austin, Texas, Emergent Technologies, Inc. (Emergent) is a leading innovation solutions company that identifies, manages,develops and partners to turn game-changing scientific discoveries into market-driven products. Emergent's diverse business and technical team along with its unique innovation process of transforming scientific breakthroughs into technology platforms with multiple applications, maximizes the value of promising ideas and underutilized intellectual properties without the risk associated with commercial development. The company applies its experience and expertise to provide investors, entrepreneurs, communities and industry partners access to innovative solutions to advance initiatives and protect and grow core businesses with novel, differentiating technology. For more information, visit the Emergent website www.emergenttechnologies.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES